Dergiler / art / 2019 / Cilt: 34 - Sayı: 1

Autoimmune Manifestations in Heterozygote Type I Complement 2 Deficiency: A Child Eventually Diagnosed With Systemic Lupus Erythematosus

Dergi
art
Sayfa
96–99
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We wish to highlight that distinctive autoimmune manifestations should guide physicians to research on monogenic lupus, particularly C2 deficiency, even in the absence of coexisting recurrent pyogenic infections.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Systemic lupus erythematosus (SLE) is an autoimmune disorder resulting in a broad spectrum of manifestations in several organs, mainly skin and kidney.
📊
Temel Bulgular & Veri:Significant hypocomplementemia, anemia, proteinuria and positive autoantibodies and coombs test led to the diagnosis of SLE.
💡
Sonuç & Katkı:We wish to highlight that distinctive autoimmune manifestations should guide physicians to research on monogenic lupus, particularly C2 deficiency, even in the absence of coexisting recurrent pyogenic infections.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Systemic lupus erythematosus (SLE) is an autoimmune disorder resulting in a broad spectrum of manifestations in several organs, mainly skin and kidney. SLE occurs with interaction of genetic and environmental factors. The most remarkable genetic predisposition to SLE is deficiency of early components of the classical complement pathway. A five-year-old, previously healthy female patient was admitted to our hospital with headache, fever, focal partial seizure, diagnosed and treated as encephalitis. She was re-admitted to our hospital at six years of age with fever, fatigue, alopecia and oral aphthous ulcers and necrotizing vasculitis on extremities. Significant hypocomplementemia, anemia, proteinuria and positive autoantibodies and coombs test led to the diagnosis of SLE. Due to early disease onset and distinct autoimmune manifestations, we diagnosed our patient with type I complement 2 (C2) deficiency with a frameshift mutation in C2 gene and a serum C2 level of <0.2 mg/dL. To our knowledge, this is the first case of genetically confirmed and successfully treated hereditary C2 deficient SLE patient diagnosed with necrotizing vasculitis. We wish to highlight that distinctive autoimmune manifestations should guide physicians to research on monogenic lupus, particularly C2 deficiency, even in the absence of coexisting recurrent pyogenic infections.

🔖

Bu Makaleye Atıf Yap

EKİNCİ, R. M. K., BALCI, S., BİŞGİN, A., ATMIŞ, B., DOĞRUEL, D., YILMAZ, M. (2019). Autoimmune Manifestations in Heterozygote Type I Complement 2 Deficiency: A Child Eventually Diagnosed With Systemic Lupus Erythematosus. art, Cilt: 34 - Sayı: 1, 96–99. https://ajindex.com/articles/149685

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Macedo AC, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol 2016;7:55
  2. Papadimitraki ED, Isenberg DA. Childhood- and adultonset lupus: an update of similarities and differences. Expert Rev Clin Immunol 2009;5:391-403
  3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725
  4. Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 2007;40:560-6
  5. Kallel-Sellami M, Laadhar L, Zerzeri Y, Makni S. Complement deficiency and systemic lupus erythematosus: consensus and dilemma. Expert Rev Clin Immunol 2008;4:629-37
  6. Lipsker DM, Schreckenberg-Gilliot C, Uring- Lambert B, Meyer A, Hartmann D, Grosshans EM, et al. Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch Dermatol 2000;136:1508-14
  7. Sallai KK, Nagy E, Bodó I, Mohl A, Gergely P. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. Scand J Rheumatol 2007;36:198-205
  8. Gheita TA, Abaza NM, Sayed S, El-Azkalany GS, Fishawy HS, Eissa AH. Cutaneous vasculitis in systemic lupus erythematosus patients: potential key players and implications. Lupus 2017:961203317739134
  9. Bennett RE, Clough JD, Calabrese LH. Fulminating vasculitis in a homozygous C2-deficient patient. Cleve Clin Q 1985;52:213-5.